Identifying Optimal Serum Urate Levels to Reduce Gout Flares in Patients Taking Urate Lowering Therapy: A Post-hoc Cohort Analysis of CARES with Consideration of Drop-out

被引:0
|
作者
Tedeschi, Sara [1 ]
Hayashi, Keigo [1 ]
Zhang, Yuqing [2 ]
Choi, Hyon K. [3 ,4 ]
Solomon, Daniel [1 ]
机构
[1] Brigham & Womens Hosp, Boston, MA USA
[2] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Dept Med, Boston, MA USA
[3] Massachusetts Gen Hosp, Lexington, MA USA
[4] Harvard Med Sch, Lexington, MA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0234
引用
收藏
页码:456 / 458
页数:3
相关论文
共 12 条
  • [1] Identifying the association between serum urate levels and gout flares in patients taking urate-lowering therapy: a post hoc cohort analysis of the CARES trial with consideration of dropout
    Tedeschi, Sara K.
    Hayashi, Keigo
    Zhang, Yuqing
    Choi, Hyon
    Solomon, Daniel H.
    ANNALS OF THE RHEUMATIC DISEASES, 2024,
  • [2] Post-hoc analysis of the CARES trial suggests delayed progression of chronic kidney disease in patients with gout during urate-lowering therapy
    Ghang, Byeongzu
    Park, Jino
    Lee, Ji Sung
    Lim, Joon Seo
    Kim, Hyunwoo
    Liew, David F. L.
    Kim, Jinseok
    Kang, Duk-Hee
    Yoo, Bin
    KIDNEY INTERNATIONAL, 2025, 107 (03) : 521 - 529
  • [3] Predictors of poor response to urate-lowering therapy in patients with gout and hyperuricemia: a post-hoc analysis of a multicenter randomized trial
    Zepeng Mu
    Wei Wang
    Jing Wang
    Wenshan Lv
    Ying Chen
    Fang Wang
    Xiaolong Yu
    Yangang Wang
    Bingfei Cheng
    Zhongchao Wang
    Clinical Rheumatology, 2019, 38 : 3511 - 3519
  • [4] Predictors of poor response to urate-lowering therapy in patients with gout and hyperuricemia: a post-hoc analysis of a multicenter randomized trial
    Mu, Zepeng
    Wang, Wei
    Wang, Jing
    Lv, Wenshan
    Chen, Ying
    Wang, Fang
    Yu, Xiaolong
    Wang, Yangang
    Cheng, Bingfei
    Wang, Zhongchao
    CLINICAL RHEUMATOLOGY, 2019, 38 (12) : 3511 - 3519
  • [5] The Effect of Decrease in Serum Urate for the Risk of Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Gout Patients: A Prospective Cohort Study
    Pang, Lei
    Xue, Xiaomei
    He, Yuwei
    Wang, Can
    Han, Lin
    Li, Maichao
    Qi, Han
    Li, Changgui
    Lu, Jie
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 3937 - 3947
  • [6] Gout Flares During the Initiation and Escalation of Treat-to-Target Urate Lowering Therapy: A Post-hoc Analysis of a Randomized Multicenter Comparative Effectiveness Trial
    Barry, Austin
    Helget, Lindsay
    Androsenko, Maria
    Wu, Hongsheng
    Kramer, Bridget
    Newcomb, Jeff
    Brophy, Mary
    Davis-Karim, Anne
    England, Bryant
    Ferguson, Ryan
    Pillinger, Michael
    Neogi, Tuhina
    Palevsky, Paul
    O'Dell, James
    Mikuls, Ted R.
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 469 - 470
  • [7] Post-hoc analysis of pegloticase pivotal trials in chronic refractory gout: relationship between fluctuations in plasma urate levels and acute flares
    Mandell, B. F.
    Fields, T. R.
    Edwards, N. L.
    Yeo, A. E.
    Lipsky, P. E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1085 - 1092
  • [8] RELATIONSHIP BETWEEN SUSTAINED LOWERING OF SERUM URATE LEVELS AND IMPROVEMENTS IN GOUT FLARES AND TOPHUS AREA: POOLED EXPLORATORY ANALYSIS OF GOUT SUBJECTS RECEIVING LESINURAD AND XANTHINE OXIDASE INHIBITOR COMBINATION THERAPY
    Terkeltaub, R.
    Perez-Ruiz, F.
    Storgard, C.
    Fung, M.
    Kopicko, J.
    Dalbeth, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 771 - 772
  • [9] Treat-to-target Urate-lowering Therapy Reduces Gout Flare Burden: Post-hoc Analysis of a Multicenter, Randomized, Double-blind, Non-inferiority Trial
    Qu, Joshua
    Helget, Lindsay
    Androsenko, Maria
    Wu, Hongsheng
    Kramer, Bridget
    Newcomb, Jefferey
    Brophy, Mary
    Davis-Karim, Anne
    England, Bryant
    Ferguson, Ryan
    Pillinger, Michael
    Neogi, Tuhina
    Palevsky, Paul
    O'Dell, James
    Mikuls, Ted R.
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1630 - 1632
  • [10] Race and Disease Severity Predict Reduced Response to Treat-to-Target Urate Lowering Therapy in Gout: Post-hoc Analysis of a Multicenter, Randomized, Double-Blind, Non-Inferiority Trial
    Helget, Lindsay
    O'Dell, James
    Newcomb, Jeff
    Androsenko, Maria
    Brophy, Mary
    Davis-Karim, Anne
    England, Bryant
    Ferguson, Ryan
    Pillinger, Michael
    Neogi, Tuhina
    Palevsky, Paul
    Wu, Hongsheng
    Mikuls, Ted
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3129 - 3131